Recombinant Human PNMT Protein, CF
R&D Systems | Catalog # 7854-MT
Key Product Details
- R&D Systems E. coli-derived Recombinant Human PNMT Protein (7854-MT)
- Quality control testing to verify active proteins with lot specific assays by in-house scientists
- All R&D Systems proteins are covered with a 100% guarantee
Source
Accession Number
Applications
Product Specifications
Source
Met1-Leu282, with a C-terminal 6-His tag
Purity
Endotoxin Level
N-terminal Sequence Analysis
Predicted Molecular Mass
SDS-PAGE
Activity
The specific activity is >2.5 pmol/min/μg, as measured under the described conditions.
Formulation, Preparation, and Storage
7854-MT
| Formulation | Supplied as a 0.2 μm filtered solution in Tris, EDTA, Brij-35 and Glycerol. |
| Shipping | The product is shipped with polar packs. Upon receipt, store it immediately at the temperature recommended below. |
| Stability & Storage | Use a manual defrost freezer and avoid repeated freeze-thaw cycles.
|
Background: PNMT
References
- Kirshner, N. et al. (1957) Biochim. Biophys. Acta. 24:658.
- Axelrod, J. (1962) J. Biol. Chem. 237:1657.
- Weil-Malherbe, H. et al. (1959) Science 129:1226.
- Ciaranello, R. D. et al. (1969) Nature 221:368.
- Saavedra, J. M. et al. (1976) Science 191:483.
- Rothballer, A. B. (1959) Pharmacol. Rev. 11:494.
- Mann, M. B. (2001) Am. J. Med. Genet. 105:312.
Long Name
Alternate Names
Gene Symbol
UniProt
Additional PNMT Products
Product Documents for Recombinant Human PNMT Protein, CF
Certificate of Analysis
To download a Certificate of Analysis, please enter a lot or batch number in the search box below.
Note: Certificate of Analysis not available for kit components.
Product Specific Notices for Recombinant Human PNMT Protein, CF
For research use only
Related Research Areas
Customer Reviews for Recombinant Human PNMT Protein, CF
There are currently no reviews for this product. Be the first to review Recombinant Human PNMT Protein, CF and earn rewards!
Have you used Recombinant Human PNMT Protein, CF?
Submit a review and receive an Amazon gift card!
$25/€18/£15/$25CAN/¥2500 Yen for a review with an image
$10/€7/£6/$10CAN/¥1110 Yen for a review without an image
Submit a review
Protocols
View specific protocols for Recombinant Human PNMT Protein, CF (7854-MT):
- Assay buffer: 25 mM MES, pH 6.0
- Hydrolysis buffer: 100 mM HEPES, pH 7.0
- Recombinant Human PNMT (rhPNMT) (Catalog # 7854-MT)
- Substrate: DL-Norepinephrine hydrochloride (Sigma, Catalog # A7256), 0.5 M stock in deionized water
- Recombinant Human Adenosylhomocysteinase/AHCY (rhAHCY) (Catalog # 6466-AH)
- Recombinant Human Adenosine Deaminase/ADA (rhADA) (Catalog # 7048-AD)
- S-adenosylmethionine (AdoMet) (Sigma, Catalog # A7007), 20 mM stock in deionized water
- Glutathione, reduced (Amresco, Catalog # 399), 250 mM stock in deionized water.
- ThioGlo® 3 Fluorescent Thiol Reagent (Covalent Associates, Inc., Catalog # T-003), 10 mM stock in DMSO
- F16 Black Maxisorp Plate (Nunc, Catalog # 475515)
- Fluorescent Plate Reader (Model: SpectraMax Gemini EM by Molecular Devices) or equivalent
- Dilute rhPNMT to 80 µg/mL in Assay Buffer.
- Create a Substrate Mixture containing 400 µM AdoMet and 1 mM DL-Norepinephrine hydrochloride in Assay Buffer.
- Combine equal volumes of rhPNMT and Substrate Mixture. As a Control, replace rhPNMT with Assay Buffer.
- Incubate reactions and control at room temperature for 30 minutes.
- Boil reactions and control at 95‑100 °C for 5 minutes. Cool samples on ice for 3 minutes.
- Create a Hydrolysis Mixture containing 25 µg/mL rhAHCY and 2.5 µg/mL rhADA in Hydrolysis Buffer.
- Add an equal volume of Hydrolysis Mixture to reactions and control.
- Incubate reactions and control at 37 °C for 1 hour.
- Prepare standard curve during incubation (step 7).
- Dilute Glutathione to 20 µM in Assay Buffer.
- Continue standard curve by performing six additional ½ dilutions in Assay Buffer.
- Load 25 µL of each curve point into the plate in triplicate. Include a standard blank of Assay Buffer only in triplicate.
- Add 25 µL of Hydrolysis Buffer to the curve wells.
- Load 50 µL of reaction(s) and control into empty wells in triplicate.
- Dilute ThioGlo to 100 µM in DMSO.
- Add 50 µL of 100 µM ThioGlo to all wells, including standard curve.
- Incubate sealed plate at room temperature for 5 minutes in the dark.
- Read at excitation and emission wavelengths of 380 nm and 445 nm (top read), respectively, in endpoint mode.
- Calculate specific activity:
|
Specific Activity (pmol/min/µg) = |
Thiol produced* (pmol) |
| Incubation time (min) x amount of enzyme (µg) |
*Derived from the reduced glutathione standard curve using linear fitting and adjusted for Control.
Per Well:
- rhPNMT: 1 µg
- DL-Norepinephrine hydrochloride: 125 µM
- AdoMet: 50 µM
- rhAHCY: 6.25 µg/mL
- rhADA: 0.625 µg/mL
- ThioGlo: 50 µM
- Glutathione Curve: 500, 250, 125, 62.4, 31.2, 15.6, 7.8 and 0 pmol
FAQs for Recombinant Human PNMT Protein, CF
-
Q: In the assay for Recombinant Human PNMT Protein, CF (Catalog # 7854-MT) what is the purpose of the Hydrolysis Micture, Glutathione, and ThioGlo?
A: The assay described on the 7854-MTproduct insert is a coupled reaction. The first step, performed by PNMT, involves the transfer of a methyl group from norepinephrine to epinephrine. The second step involves conversion of s-adenylsylhomocysteine (a byproduct of the first reaction) to homocysteine, which has a detectable free thiol. This second step utilizes the Hydrolysis Mixture.
Glutathione also has a free thiol, so it can be used as a standard curve for the reaction.
ThioGlo is a thiol-reactive fluorescent probe. Upon reaction with a thiol group, a fluorescent adduct is formed that displays excitation/emission maxima of 380/445 nm, respectively.